J. P. BAKER JR., M.D.; NATHAN BLOOM, M.D.
Verodigen, a gitalin-like fraction of digitalis, has been used for a number of years in several European countries, and in some instances has largely replaced the galenical preparations of digitalis. There have been a number of reports on its usefulness,1, 2, 3 which give the impression that it is considered superior to digitalis in several ways. From a clinical standpoint, it is said to be absorbed more readily and to exert its effect on the heart more rapidly than digitalis. It is claimed, moreover, that this drug is borne by the gastrointestinal tract better, causing nausea and vomiting less often
Learn more about subscription options.
Register Now for a free account.
BAKER JP, BLOOM N. CLINICAL STUDIES ON VERODIGEN, A DIGITALIS GLUCOSIDE(CLINICAL STUDIES ON VERODIGEN, A DIGITALIS GLUCOSIDE*). Ann Intern Med. 1936;10:605–621. doi: 10.7326/0003-4819-10-5-605
Download citation file:
Published: Ann Intern Med. 1936;10(5):605-621.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only